drugset / Trial / NCT01388842
Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
Phase 2
Completed
92 enrolled
Epicentre
Harvard Medical School (HMS and HSDM) · collabMassachusetts General Hospital · collabMbarara University of Science and Technology · collabMedecins Sans Frontieres, Netherlands · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess if adding inhaled Nitric Oxide to other malaria treatments can improve the outcome of cerebral malaria in children aged 2months to 12 years.
Timeline
- Start
- 2011-09
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitric Oxide | Other / unclassified | 80 ppm | Inhaled |